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Polyphenols, ubiquitously present in the food we consume, may modify the gut microbial
composition and/or activity, and moreover, may be converted by the colonic microbiota to
bioactive compounds that influence host health. The polyphenol content of fruit and vegetables
and derived products is implicated in some of the health benefits bestowed on eating fruit and
vegetables. Elucidating the mechanisms behind polyphenol metabolism is an important step in
understanding their health effects. Yet, this is no trivial assignment due to the diversity
encountered in both polyphenols and the gut microbial composition, which is further confounded
by the interactions with the host. Only a limited number of studies have investigated the impact of
dietary polyphenols on the complex human gut microbiota and these were mainly focused on
single polyphenol molecules and selected bacterial populations. Our knowledge of gut microbial
genes and pathways for polyphenol bioconversion and interactions is poor. Application of specific
in vitro or in vivo models mimicking the human gut environment is required to analyse these
diverse interactions. A particular benefit can now be gained from next-generation analytical tools
such as metagenomics and metatranscriptomics allowing a wider, more holistic approach to the
analysis of polyphenol metabolism. Understanding the polyphenol–gut microbiota interactions and
gut microbial bioconversion capacity will facilitate studies on bioavailability of polyphenols in the
host, provide more insight into the health effects of polyphenols and potentially open avenues for
modulation of polyphenol bioactivity for host health.
Introduction
The human intestine harbours a complex microbial
ecosystem comprising a considerable metabolic versatility,
using biological pathways that humans have not evolved
(Qin et al., 2010). This capacity of the gut microbiome,
encoded by the collective genomes of the gut microbiota or
gut metagenome, includes the metabolism of indigestible
polyphenols derived from fruit and vegetables. Polyphenols
are phytochemicals abundantly present in our diet in
diverse products including tea, coffee, wine, fruit, vege-
tables and chocolate. Daily intake is estimated at 100–
150 mg per day in Western populations (Manach et al.,
2004). Polyphenol consumption has been implicated to
have diverse benefits such as improved gut health and
reduced risk of coronary heart disease, amongst others
(Fava et al., 2006; Romier et al., 2009). However, despite
mechanistic evidence for these potential effects, in most
cases they are far from being clearly proven.
Only a fraction of the known polyphenols is present in
edible food crops and products, such as the anthocyanins
colouring berries and tannins responsible for the specific
astringent taste of wine and the bitterness of chocolate.
Three predominant groups of dietary polyphenols are
flavonoids, lignans and phenolic acids. In the case of
flavonoids, monomers (catechins; present in tea) and
polymers (proanthocyanidins; present in wine) can be
distinguished. Moreover, nearly 80 % of the flavonoids
occur as glycosides in plants and derived food products
(Pe´rez-Jime´nez et al., 2010). While some flavonoids are
ubiquitous, others are almost exclusively found in
particular foods such as daidzein in soy.
Many studies on polyphenols to date have focused on the
bioactivities of one specific molecule in aglycone form,
often at supraphysiological doses, whereas foods contain
complex, often poorly characterized mixtures with multiple
additive or interfering activities (Steiner et al., 2008).
Furthermore, recent human studies indicate that plasma
concentrations and urinary excretions of microbial meta-
bolites can exceed those of host origin, especially for
polyphenols that are not easily absorbed in the upper
gastro-intestinal tract and persist to the colon (Manach
et al., 2009; van Dorsten et al., 2010). The emerging
consensus is that the gut microbiota may play a crucial role
in the potential health benefits of polyphenols (Crozier
et al., 2009). This review addresses approaches for inves-
tigating this polyphenol–microbiota interaction, part of the
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polyphenol–microbiota–host triangle. First, current know-
ledge on the bioconversion and bioavailability of poly-
phenols and their impact on the gut microbiota is outlined.
Novel microbiomic approaches using emerging technolo-
gies in combination with appropriate models to study the
microbial metabolic genes and pathways involved will be
discussed.
Bioavailability of dietary polyphenols
Bioavailability (of polyphenols) encompasses dissolution
and absorption, distribution to and disposition in target
tissues, metabolism and excretion (Fig. 1). It is influenced
by numerous, sometimes interrelated, factors, such as
variation in food content, matrix and processing, but also
genetic, microbial and dietary factors, as observed in
human intervention trials (Bolca et al., 2010; van Dorsten
et al., 2010). Despite the growing awareness of the poor
bioavailability of native polyphenols, the full effects of
intestinal digestion, phase I and II metabolism, and, in
particular, microbial metabolism of most polyphenols are
poorly characterized (Fig. 1).
The first step upon ingestion is the release of polyphenols
from their matrix. Deglycosylation of flavonoid glycosides,
the cleavage of polymeric proanthocyanidins, as well as the
hydrolysis of esterified phenolic acids are, for most
compounds, a prerequisite for absorption through the
intestinal barrier (Manach et al., 2004). These hydrolyses
can be performed from the small intestine onward by either
brush border or microbial enzymes. Aglycones, monomers
to trimers of flavonols, and some intact glycosides
(anthocyanins) can rapidly be absorbed by enterocytes,
most likely by passive diffusion. During intestinal absorp-
tion and passage in the liver, polyphenols are extensively
glucuronidated and/or sulphated (phase II metabolism),
whereas phase I metabolism (oxidation/reduction reac-
tions) appears to be minor (Lampe, 2009). As a result,
circulating polyphenols are mainly glucuronides. Polyphenol
plasma curves often show a second peak, characteristic of
enterohepatic circulation. Although faecal excretion is low,
urinary recoveries of the parent polyphenols account for only
a small fraction of the ingested doses. This indicates that a
substantial part is transformed or degraded in the gut. Faecal
incubation of anthocyanins, for example, results in a rapid
Fig. 1. Metabolic fate of dietary polyphenols.
Partial absorption of polyphenols occurs in the
small intestine, with modification by phase I
and phase II enzymes, excretion with bile back
into the small intestine, deconjugation by
microbial enzymes and microbial conversion
of the polyphenols in the colon, absorption of
microbial metabolites or faecal excretion,
deconjugation and excretion via bile or urine.
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breakdown to their phenolic end products (Fleschhut et al.,
2006). This rapid breakdown of the parent polyphenols by
the gut microbiota explains their apparent poor bioavail-
ability in pharmacokinetic studies.
Microbial metabolism of polyphenols
In general, the first step in polyphenol degradation involves
the release of aglycones and oligomers by microbial
glycosidases and esterases, which enhances their absorption.
Secondly, microbial glucuronidases and sulphatases decon-
jugate the phase II metabolites extruded via the bile, thus
enabling reuptake. Finally, several microbial transformations
of the polyphenolic core, e.g. ring fission by Eubacterium
ramulus (Clavel et al., 2006), generate metabolites that may
have altered bioactivities with respect to human health.
Degradation of naringenin and most likely other polyphenols
as well by E. ramulus putatively involves the enzymes
calchone isomerase and phloretin hydrolase (Herles et al.,
2004; Schoefer et al., 2004). Dehydroxylation and demethy-
lation of both intermediates and end products can occur at
various points in the pathway. Overall, this extensive
microbial metabolism ultimately truncates the structural
diversity of the native polyphenols to a limited number of
mainly simple aromatic metabolites. The microbial conver-
sion rate of polyphenols will also influence their bioavail-
ability, as rapidly converted native as well as intermediate
polyphenolic compounds are less available for absorption
relative to their (phenolic) end products. The majority of
these microbial metabolites undergo phase I/II metabolism
during and after uptake through the intestinal epithelium
and are detected as such in urine, serum and biopsies (Bolca
et al., 2010). As a consequence, the gut lumen, particularly
of the ileum, is the only host site where relatively high
concentrations of native polyphenols can be expected,
whereas other target sites are mainly exposed to (conjugated)
microbial degradation products. These conversions are
characterized by a large inter-individual variation (Gross
et al., 2010), as also illustrated by the bioactivation of dietary
phyto-oestrogens and consequent exposure to oestrogeni-
cally active metabolites (Bolca et al., 2009).
Our current knowledge on the gut microbes, their enzymes
and metabolic routes involved in polyphenol conversions,
is limited to a few well-studied model compounds. For
instance, the microbial conversion of the major green tea
polyphenols catechin, epicatechin, epicatechin gallate and
epigallocatechin gallate, results in 4-hydroxybenzoic acid
and vanillic acid, which are both converted to hippuric acid
derivatives upon absorption (Feng, 2006). To date, several
specific gut microbes and microbial consortia have been
identified that convert one or the other polyphenol, usually
based on selective enrichment of faecal cultures (recently
reviewed by Selma et al., 2009). However, there is a
mammoth task ahead if one considers the hundreds of
different polyphenols and, so far, just a dozen bacterial
polyphenol metabolism-related genes/proteins that have
been identified with a further approximately 800 hypo-
thetical genes/protein linked to polyphenols in general.
Modulation of gut microbiota by polyphenols
There are remarkably few studies investigating the
influence of polyphenols on the composition and activity
of the gut microbial community. This represents a
significant gap in our understanding of the polyphenol–
microbe interactions. Nevertheless, there is evidence from
in vitro, animal and human studies that certain doses of
selected polyphenols influence gut microbial populations,
and while certain bacterial groups can be inhibited, others
can thrive in the vacant niche of the ecosystem. For
example, (+)-catechin significantly inhibited growth of
Clostridium histolyticum, whereas growth of members of
the Clostridium coccoides–Eubacterium rectale group and
Escherichia coli was significantly enhanced and growth of
Bifidobacterium and Lactobacillus spp. remained relatively
unaffected (Tzounis et al., 2008). Moreover, two rat studies
showed an impact of a polyphenol-rich diet on particular
gut bacterial populations. The Clostridium leptum cluster
decreased significantly, while the Bacteroides group
increased significantly when rats were given a tannin-rich
diet (Smith et al., 2005). Red-wine-polyphenols-treated
rats had significantly lower levels of Clostridium spp. and
higher levels of Lactobacillus spp. (Dolara et al., 2005).
These studies applied both conventional culturing as well
as molecular methods such as fluorescence in situ
hybridization and denaturing gradient gel electrophoresis,
which essentially target either well-known groups or
provide comparative profiles rather than direct microbial
identification. Therefore, it would be valuable to perform
more global diversity studies on gut microbial modulation
by polyphenols with ‘omics’ technologies. These give a
more in-depth, unbiased microbial analysis beyond the
group level and involve multiple species, addressing
whether or not all members of a bacterial group are
equally affected by a polyphenol intervention.
An interesting aspect of the polyphenol–microbe inter-
action is the underlying mechanisms of action of
polyphenols on bacterial cells. The antimicrobial action
of different polyphenols is especially notable and several
non-exclusive mechanisms have been proposed (Table 1).
For example, polyphenols can bind to bacterial cell
membranes in a dose-dependent manner, thereby disturb-
ing membrane function and, consequently, inhibiting cell
growth. Moreover, differences in antimicrobial activity of
catechins might be due to differences in binding affinity to
the actual lipid bilayer of the bacterial cell membrane (Sirk
et al., 2009). Another hypothesis leans towards the
formation of polyphenols–metal ions complexes, which
in turn would lead to iron deficiency in the gut and could,
therefore, affect sensitive bacterial populations (Smith
et al., 2005). Overall, some mechanistic insights in poly-
phenol–microbiota interactions are being generated, but
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further more detailed studies are required for a better
understanding.
Models facilitate mechanistic studies
It is a particularly challenging task to study polyphenol–
microbiota interactions and their relevance to human
health. The high diversity of polyphenols, their bioavail-
abilities and the numerous molecular mechanisms by which
they may trigger health responses, the large interindividual
variability in both composition and activity of gut micro-
biota, all contribute to the complexity. Moreover, there is an
inexhaustible list of interfering factors such as diet,
polyphenol matrix and gut transit time. Understanding
how these interact and contribute to the in situ exposure is
crucial for the proper interpretation of biological responses,
or the lack thereof, in observational and intervention
studies. Furthermore, knowledge of the critical parameters
involved will help to identify host subpopulations that may
benefit or be at risk upon polyphenol exposure and to
substantiate health claims. However, controlling and
evaluating all, often interrelated, variables within one
experimental setting is not feasible. Consequently, to get
the whole picture, a multidisciplinary approach, combining
both in vitro and in vivo studies, is the key to success.
Currently available in vitro intestinal models range from
rather basic faecal incubations to multistage continuous
culture systems (Macfarlane et al., 1998; Minekus et al.,
1999; Molly et al., 1993). These models lack a host
compartment and, therefore, focus on the microbial aspect
alone. Consequently, they are of great value as they allow
for mechanistic studies with easy sampling and differenti-
ation between fully controlled variables. Parallel faecal
incubations are particularly suitable for assessment of the
interindividual variation in microbial polyphenol meta-
bolism (Gross et al., 2010) or for comparison of different
sources or doses of polyphenols (Bolca et al., 2009). This is
in contrast with human crossover studies which may be
clouded by false washout phases between different doses of
polyphenols due to adaptive metabolism of the gut
microbes and by dietary background noise and variation.
Longitudinal experiments with continuous culture model
systems in turn, are preferred to study polyphenol-induced
modulation of colon microbiota and the persistence of
change.
In some cases, the use of animal models is necessary due to
difficulties in accessing intestinal locations in humans.
Inoculation of germ-free rodents with a human faecal
microbiota, human-microbiota associated (HMA) animals,
effectively mimics human microbial metabolism and thus
provides a reliable model to study the human gut microbial
ecosystem as well as metabolism (Hirayama & Itoh, 2005;
Turnbaugh & Gordon, 2009). Some HMA rodent studies
on catechin and isoflavone metabolism have been per-
formed, but without investigating the effects on composi-
tion and activity of the microbial community itself (Bowey
et al., 2003; Lhoste et al., 2003). Germ-free rodents
inoculated with specific bacterial strains have been used
to study polyphenol conversion, but appear to be of limited
added value for studying microbial conversions as they
have so far just confirmed in vitro results (Blaut et al., 2003;
Possemiers et al., 2008).
Analytical platforms and data integration
Many of the insights gained into the interaction of
polyphenols with gut microbiota are based on experiments
with a single polyphenol and/or individual micro-organ-
isms. At present, next-generation sequencing platforms,
high-throughput proteomics and metabolomics provide
the opportunity to explore the taxonomic, protein-coding
gene or expression diversity by applying more compre-
hensive and less biased measurements to all systems
involved, i.e. diet, microbiota and host. Each technique
offers specific insights (Fig. 2) and in combination with
novel pattern recognition techniques they can accelerate
the research in this field (van Velzen et al., 2009).
Phylogenetic analyses were the first to benefit from the high-
throughput sequencing revolution, enabling (partial) 16S
rRNA gene sequencing on metagenomic samples. Simul-
taneously, and based on the increased sequence data
available, 16S rRNA-based microarrays have been developed
for diversity analysis of the gut or other environments
(DeSantis et al., 2007; Rajilic´-Stojanovic´ et al., 2009). Both
methods are still equally applicable. Direct metagenomic
sequencing is currently generating a qualified understanding
of the metabolic potential embedded in selected gene pools of
the gut microbiota. Moreover, the metagenomic sequencing
data offer a solid basis for post-genomic research strategies.
Post-genomic functional screening of metagenomic libraries
Table 1. Proposed mechanisms of antimicrobial activity of polyphenols
Mechanism Compound References
Membrane interaction Green tea polyphenols, epicatechin gallate Kumazawa et al. (2004), Sirk et al. (2009), Stapleton
et al. (2007)
DNA gyrase inhibition Quercetin Cushnie & Lamb (2005)
Metal sequestering Tannins Smith et al. (2005)
Enzyme inhibition Epigallocatechin gallate Navarro-Martı´nez et al. (2005)
Reactive oxygen generation Epigallocatechin gallate Arakawa et al. (2004)
Inhibition of virulence factors Tea polyphenols, resveratrol Evensen & Braun (2009), Wang et al. (2006)
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directly identifies metagenomic fragments encoding a
metabolic function (Beloqui et al., 2006). A high-throughput
assay is critical for this. We investigated the possibility of
identifying gut microbial genes for catechin bioconversion
using clones from a metagenomic library (Manichanh et al.,
2006) by measuring catechin conversion by HPLC. However,
several challenges confounded our efforts to optimize assay
conditions; in particular, differential catechin depletion
occurred without actual conversion, likely due to the
interaction of the catechins with the bacterial membrane or
possibly through binding to cellular proteins. In addition,
metagenomic library screening is probably most successful
for functions encoded by a single gene or operon, while
(certain) polyphenol conversions may require a consortium
of microbes, which limits its applications, unless multiple
screening assays are combined.
Metatranscriptomics and metaproteomics are being
applied to the gut microbial community and provide
functional analysis of the gut microbial species beyond a
mere phylogenetic description. While metatranscriptomics
has the potential to reveal the nearly instantaneous
responses to environmental fluctuations, metaproteomics
more directly reflects the immediate catalytic potential of a
microbial community. In the context of polyphenol–
microbiota interactions, such approaches can be adopted
to identify genes and micro-organisms involved in
polyphenol (in)activation and conversion, to reconstruct
metabolic pathways, and to monitor how microbial
communities adjust their metabolic activities upon poly-
phenol administration. Metatranscriptomic analyses enable
the detection of changes in gene expression over time or
under various physiological/environmental conditions,
which will help to link community structure with function,
and genotypes with phenotypes (Turnbaugh & Gordon,
2009). For the human gut, this is facilitated by a catalogue
of non-redundant human intestinal microbial genes,
indicating that individuals share about 38 % of their gene
pool, identifying what is called the ‘minimal gut genome’
and ‘minimal gut metagenome’ (Qin et al., 2010). We
assume that this catalogue also harbours some of the genes
involved in polyphenol conversion, enabling us to identify
genes encoding polyphenol metabolism by comparative
sequence analysis of metatranscriptomes before and after a
polyphenolic intervention. The application of shotgun
metaproteomics to human distal gut microbial samples has
Fig. 2. Schematic representation of functional microbiome approaches for investigation of the effects of polyphenols on the
human gut microbiota, including metabolic analyses, metatranscriptomics and shotgun metaproteomics. The latter two
protocols follow methods presented previously (Turnbaugh & Gordon, 2009; Verberkmoes et al., 2009). LC-MS/MS, liquid
chromatography–tandem mass spectrometry; ES, electrospray ionization.
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been demonstrated (Verberkmoes et al., 2009). Interest-
ingly, human proteins related to innate immunity and
inflammation response were also identified amongst the
microbial proteins highlighting the interplay between gut
microbes and host. Eventually, environmental proteomics
and proteogenomics of the gut ecosystem may be applied
to link environmental changes, including polyphenol
interventions, to protein level changes, as has been done
for a less complex microbial community (Denef et al.,
2010). The role of metabolomics will also increase in
terms of identification of microbial polyphenol metabo-
lites, monitoring not only shifts in polyphenol levels and
their respective metabolites upon interaction with gut
microbes but also changes in general microbial metabolites,
such as short chain fatty acids, as a result of polyphenol
exposure.
We are currently investigating these approaches to study
the effects of dietary polyphenol mixes on the human gut
microbiota both in vitro (Gross et al., 2010) and in vivo
(van Duynhoven et al., 2010). The influence of polyphenol
extracts from black tea on the intestinal microbiota was
assessed in a continuous gut model (Fig. 3a). Quantitative
PCR showed the inhibitory effect of tea polyphenols on the
microbial community, which was more pronounced upon
continuous feeding than after a single bolus. Phylogenetic
information could also be directly correlated with meta-
bolite data in vivo, as was demonstrated for a small human
study in which several microbial species were found to
correlate to urinary metabolites, some of which appear in
polyphenol bioconversion pathways (Li et al., 2008). In a
human nutrikinetic study with 20 individuals consuming a
bolus dose of tea polyphenols, we found correlations
between the microbial diversity, as measured with the
Human Intestinal Tract Chip (HITChip) and nutrikinetic
phenotypes. Specifically, the Actinobacteria and Clostridium
clusters correlated with degradation of catechin-type
structures (van Duynhoven et al., 2010). Ultimately, using
the actual genomic diversity rather than microbial diversity
for correlation is expected to give a more detailed insight
into metabolome–microbiome interactions. In vitro gut
models challenged with polyphenols are a feasible means
for obtaining initial data on the impact of polyphenols on
phylogeny and functionality (Fig. 3b), especially as they are
amenable for use to isolate quality mRNA for metatran-
scriptomics. Overall, the initial exposure to polyphenols
will likely upregulate polyphenol-induced stress mechan-
isms while longer term exposure should also induce
polyphenol-resistance and bioconversion genes. These
preliminary data will facilitate identification of biomar-
kers/targets for subsequent application in human faecal
samples upon dietary interventions (Fig. 2). Functions may
be tentatively assigned to the ORFs/genes identified
based on homology comparisons and correlation to
metabolite data, and eventually confirmed by biochemical
tests.
The bottle neck remaining is no longer the ability to
generate data, but the ability to process these data
efficiently in a coherent manner. Though diversity
analysis tools are now integrated into pipelines such as
QIIME (Caporaso et al., 2010), processing these large
datasets remains a challenge. Integrating the disparate
information gained by these novel analytical platforms in
a systems biology approach may lead to workable, testable
hypotheses for the impact of polyphenols on the
microbial composition and human health, and to the
development of fundamental understanding of these
complex systems (Steiner et al., 2008; van Duynhoven
et al., 2010).
Fig. 3. (a) Total bacterial counts as measured by SYBR-green-based qPCR (Nadkarni et al., 2002) in a SHIME system fed
(arrows) with 1000 mg tea polyphenols administered as either a single bolus or part of the daily feeding. Vessels mimicking the
ascending (#), transverse (g) and descending (h) colon sections are indicated. (b) General experimental design for studying
polyphenol microbiota interactions using an in vitro gut model. This includes periods for stabilization of the ecosystem (control),
single and/or a continuous dosing of polyphenols to the model (intervention) and a washout phase to determine the persistence
of change. Samples are withdrawn at least daily to measure microbial diversity (e.g. HITChip or 16S rRNA gene sequencing)
and polyphenol metabolite (NMR, GC-MS) analysis and for the more detailed metatranscriptomic analysis at key time points
(arrows) during the intervention period.
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Conclusions
Key challenges of studying polyphenol metabolism in a
dietary background are the variability in the composition
and activity of the gut microbial community, as well as the
diversity in polyphenolic mixes, combined with their
variable and typically low abundance in the diet. Though
many effects of polyphenols on gut microbes were revealed
using conventional approaches, their exact mechanisms of
action have not yet been fully established. The emerg-
ing high-throughput meta-genomic, -transcriptomic and
-proteomic, and high-throughput metabolomic technolo-
gies will accelerate the elucidation of the species/consortia
and pathways involved in polyphenol degradation and
resistance. Moreover, holistic approaches will provide a
superior description of the complexity of polyphenol–
microbiota interactions and more comprehensive insights
into their physiological relevance. Using various in vitro
and animal models for easily accessible, high quality
samples in combination with the advanced analytical
techniques has the potential to continue to facilitate under-
standing of the metabolic processes. Application of these
technologies to human faecal samples requires further
investigation to determine how these samples reflect
metabolism inside the gut. Once suitable targets have been
identified in more controlled environments, the step
linking the microbial metabolism to host metabolism can
be made. In addition, as gut microbial metabolism and
host metabolism are intimately linked through exchange of
metabolites, metabolomic analyses can capture informa-
tion on the actual exposure and response of the host, for
example, by analysing metabolites in plasma and urine in
response to a polyphenol intervention (van Dorsten et al.,
2010). Knowledge of the gut microbial genes/pathways and
cellular mechanisms of action of polyphenols on the
human gut microbial ecosystem will allow us to better
assess the fate of polyphenols and, ultimately, enhance/
improve our understanding of the impact of polyphenols
on host health.
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